Folate nutrition and blood–brain barrier dysfunction

Current Opinion in Biotechnology

Volumn 44, Issue , 2017, Pages 146-152

  Stover, Patrick J ^a   Durga, Jane ^b   Field, Martha S ^a  

^a Department of Obstetrics Gynecology   (United States)

^b NESTLÉ RESEARCH CENTER   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD; DIAGNOSIS; METABOLISM; NUTRIENTS; NUTRITION;

BARRIER FUNCTIONS; BIOLOGICAL PROCESS; CELLULAR NUTRIENTS; CHRONIC DISEASE; DIETARY SOURCES; ESSENTIAL NUTRIENTS; NEURONAL FUNCTION; NEUROPSYCHIATRIC DISORDER;

DISEASES;

FOLIC ACID; RIBOFLAVIN;

BLOOD BRAIN BARRIER; BLOOD BRAIN BARRIER DYSFUNCTION; CELL TRANSPORT; CEREBROSPINAL FLUID; CHRONIC DISEASE; DRUG ADMINISTRATION; DRUG MEGADOSE; FOLIC ACID DEFICIENCY; HUMAN; INBORN ERROR OF METABOLISM; MENTAL DISEASE; METABOLIC DISORDER; NERVE FUNCTION; NEUROLOGIC DISEASE; NUTRITIONAL HEALTH; NUTRITIONAL STATUS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; DIET; METABOLISM; PATHOLOGY;

BLOOD-BRAIN BARRIER; DIET; FOLIC ACID; HUMANS;

EID: 85012100252     PISSN: 09581669     EISSN: 18790429     Source Type: Journal    
DOI: 10.1016/j.copbio.2017.01.006     Document Type: Review

References (78)

1. 1 Trumbo, P.R., Challenges with using chronic disease endpoints in setting dietary reference intakes. Nutr Rev 66 (2008), 459–464.
2. 2 Herbert, V., The five possible causes of all nutrient deficiency: illustrated by deficiencies of vitamin B 12 and folic acid. Aust N Z J Med 2 (1972), 69–77.
3. 3•• Molero-Luis, M., Serrano, M., O'Callaghan, M., Sierra, C., Perez-Duenas, B., Garcia-Cazorla, A., Artuch, R., Clinical, etiological and therapeutic aspects of cerebral folate deficiency. Expert Rev Neurother 15 (2015), 793–802 Comprehensive review of causes and consequences of brain folate deficiency.
4. 4 Ho, A., Michelson, D., Aaen, G., Ashwal, S., Cerebral folate deficiency presenting as adolescent catatonic schizophrenia: a case report. J Child Neurol 25 (2010), 898–900.
5. 5 Papakostas, G.I., Effect of adjunctive L-methylfolate 15 mg among inadequate responders to SSRIs in depressed patients who were stratified by biomarker levels and genotype: results from a randomized clinical trial. J Clin Psychiatry 75 (2014), 855–863.
6. 6 Papakostas, G.I., et al. L-methylfolate as adjunctive therapy for SSRI-resistant major depression: results of two randomized, double-blind, parallel-sequential trials. Am J Psychiatry 169 (2012), 1267–1274.
7. 7 Wolff, T., Witkop, C.T., Miller, T., Syed, S.B., Folic Acid Supplementation for the Prevention of Neural Tube Task, U.S. Syntheses, Formerly Systematic Evidence. 2009, Agency for Healthcare Research and Quality, Rockville (MD).
8. 8 Suren, P., Association between maternal use of folic acid supplements and risk of autism spectrum disorders in children. JAMA 309 (2013), 570–577.
9. 9 Kronenberg, G., Colla, M., Endres, M., Folic acid, neurodegenerative and neuropsychiatric disease. Curr Mol Med 9 (2009), 315–323.
10. 10 Blount, B.C., Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implications for cancer and neuronal damage. Proc Natl Acad Sci U S A 94 (1997), 3290–3295.
11. 11 Ames, B.N., DNA damage from micronutrient deficiencies is likely to be a major cause of cancer. Mutat Res 475 (2001), 7–20.
12. 12 Choi, S.W., Mason, J.B., Folate and carcinogenesis: an integrated scheme. J Nutr 130 (2000), 129–132.
13. 13 Pogribny, I.P., et al. Breaks in genomic DNA and within the p53 gene are associated with hypomethylation in livers of folate/methyl-deficient rats. Cancer Res 55 (1995), 1894–1901.
14. 14 Kim, Y.I., Folate and cancer prevention: a new medical application of folate beyond hyperhomocysteinemia and neural tube defects. Nutr Rev 57 (1999), 314–321.
15. 15 Fox, J.T., Stover, P.J., Folate-mediated one-carbon metabolism. Vitam Horm 79 (2008), 1–44.
16. 16 Tibbetts, A.S., Appling, D.R., Compartmentalization of Mammalian folate-mediated one-carbon metabolism. Annu Rev Nutr 30 (2010), 57–81.
17. 17 Fox, J.T., Stover, P.J., Folate-mediated one-carbon metabolism. Vitam Horm 79 (2008), 1–44.
18. 18 Anderson, D.D., Woeller, C.F., Chiang, E.P., Shane, B., Stover, P.J., Serine hydroxymethyltransferase anchors de novo thymidylate synthesis pathway to nuclear lamina for DNA synthesis. J Biol Chem 287 (2012), 7051–7062.
19. 19 Field, M.S., Nuclear enrichment of folate cofactors and methylenetetrahydrofolate dehydrogenase 1 (MTHFD1) protect de novo thymidylate biosynthesis during folate deficiency. J Biol Chem 289 (2014), 29642–29650.
20. 20 Field, M.S., Kamynina, E., Watkins, D., Rosenblatt, D.S., Stover, P.J., Human mutations in methylenetetrahydrofolate dehydrogenase 1 impair nuclear de novo thymidylate biosynthesis. Proc Natl Acad Sci U S A 112 (2015), 400–405.
21. 21 Stover, P.J., Physiology of folate and vitamin B12 in health and disease. Nutr Rev 62:Pt. 2 (2004), S3–12 discussion S13.
22. 22 Clarke, S., Banfield, K., S-adenosylmethionine-dependent methyltransferases. Carmel, R., Jacobson, D.W., (eds.) Homocysteine in Health and Disease, 2001, Cambridge Press, Cambridge.
23. 23 Herbig, K., Cytoplasmic serine hydroxymethyltransferase mediates competition between folate-dependent deoxyribonucleotide and S-adenosylmethionine biosyntheses. J Biol Chem 277 (2002), 38381–38389.
24. 24 Friso, S., A common mutation in the 5,10-methylenetetrahydrofolate reductase gene affects genomic DNA methylation through an interaction with folate status. Proc Natl Acad Sci U S A 99 (2002), 5606–5611.
25. 25 Friso, S., Choi, S.W., Dolnikowski, G.G., Selhub, J., A method to assess genomic DNA methylation using high-performance liquid chromatography/electrospray ionization mass spectrometry. Anal Chem 74 (2002), 4526–4531.
26. 26 Jaenisch, R., Bird, A., Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet 33:Suppl (2003), 245–254.
27. 27 Huang, C., Sloan, E.A., Boerkoel, C.F., Chromatin remodeling and human disease. Curr Opin Genet Dev 13 (2003), 246–252.
28. 28 Mashiyama, S.T., Uracil in DNA, determined by an improved assay, is increased when deoxynucleosides are added to folate-deficient cultured human lymphocytes. Anal Biochem 330 (2004), 58–69.
29. 29 Basten, G.P., Sensitivity of markers of DNA stability and DNA repair activity to folate supplementation in healthy volunteers. Br J Cancer 94 (2006), 1942–1947.
30. 30 Melnyk, S., Uracil misincorporation, DNA strand breaks, and gene amplification are associated with tumorigenic cell transformation in folate deficient/repleted Chinese hamster ovary cells. Cancer Lett 146 (1999), 35–44.
31. 31 Sharma, G.S., Kumar, T., Dar, T.A., Singh, L.R., Protein N-homocysteinylation: from cellular toxicity to neurodegeneration. Biochim Biophys Acta 1850 (2015), 2239–2245.
32. 32•• Geldenhuys, W.J., Mohammad, A.S., Adkins, C.E., Lockman, P.R., Molecular determinants of blood–brain barrier permeation. Ther Deliv 6 (2015), 961–971 Excellent review on the delivery of molecules across the blood–brain barrier.
33. 33• Spector, R., Robert Snodgrass, S., Johanson, C.E., A balanced view of the cerebrospinal fluid composition and functions: focus on adult humans. Exp Neurol 273 (2015), 57–68 Review of cerebral spinal fluid functions in adults.
34. 34 Liu, W.Y., Wang, Z.B., Zhang, L.C., Wei, X., Li, L., Tight junction in blood–brain barrier: an overview of structure, regulation, and regulator substances. CNS Neurosci Ther 18 (2012), 609–615.
35. 35 Campos-Bedolla, P., Walter, F.R., Veszelka, S., Deli, M.A., Role of the blood–brain barrier in the nutrition of the central nervous system. Arch Med Res 45 (2014), 610–638.
36. 36 Spector, R., Johanson, C.E., Vitamin transport and homeostasis in mammalian brain: focus on Vitamins B and E. J Neurochem 103 (2007), 425–438.
37. 37 Regland, B., Abrahamsson, L., Blennow, K., Gottfries, C.G., Wallin, A., Vitamin B12 in CSF: reduced CSF/serum B12 ratio in demented men. Acta Neurol Scand 85 (1992), 276–281.
38. 38 Spector, R., Johanson, C.E., Vectorial ligand transport through mammalian choroid plexus. Pharm Res 27 (2010), 2054–2062.
39. 39 Erlacher, M., Reversible pancytopenia and immunodeficiency in a patient with hereditary folate malabsorption. Pediatr Blood Cancer 62 (2015), 1091–1094.
40. 40 Qiu, A., Identification of an intestinal folate transporter and the molecular basis for hereditary folate malabsorption. Cell 127 (2006), 917–928.
41. 41•• Quijada-Fraile, P., et al. Follow-up of folinic acid supplementation for patients with cerebral folate deficiency and Kearns–Sayre syndrome. Orphanet J Rare Dis, 9, 2014, 217 Effacacy of high dose folinic acid thereapy.
42. 42 Suh, J.R., Herbig, A.K., Stover, P.J., New perspectives on folate catabolism. Annu Rev Nutr 21 (2001), 255–282.
43. 43 Marques, F., Sousa, J.C., Sousa, N., Palha, J.A., Blood–brain-barriers in aging and in Alzheimer's disease. Mol Neurodegen, 8, 2013, 38.
44. 44 Nongnuch, A., Panorchan, K., Davenport, A., Brain-kidney crosstalk. Crit Care (Lond, Engl), 18, 2014, 225.
45. 45 Liu, M., et al. Acute kidney injury leads to inflammation and functional changes in the brain. JASN 19 (2008), 1360–1370.
46. 46 Algotsson, A., Winblad, B., The integrity of the blood–brain barrier in Alzheimer's disease. Acta Neurol Scand 115 (2007), 403–408.
47. 47 Mooradian, A.D., Effect of aging on the blood–brain barrier. Neurobiol Aging 9 (1988), 31–39.
48. 48 Lehmann, M., Regland, B., Blennow, K., Gottfries, C.G., Vitamin B12-B6-folate treatment improves blood–brain barrier function in patients with hyperhomocysteinaemia and mild cognitive impairment. Dement Geriatr Cogn Disord 16 (2003), 145–150.
49. 49 Smythies, J.R., Abnormalities of one-carbon metabolism in psychiatric disorders: study of methionine adenosyltransferase kinetics and lipid composition of erythrocyte membranes. Biol Psychiatry 21 (1986), 1391–1398.
50. 50 Ramaekers, L.H., The, T.S., Maternal anticonvulsants and perinatal risk. Eur J Obstet Gynecol Reprod Biol 5 (1975), 277–282.
51. 51 Frye, R.E., Sequeira, J.M., Quadros, E.V., James, S.J., Rossignol, D.A., Cerebral folate receptor autoantibodies in autism spectrum disorder. Mol Psychiatry 18 (2013), 369–381.
52. 52 Sadighi, Z., Butler, I.J., Koenig, M.K., Adult-onset cerebral folate deficiency. Arch Neurol 69 (2012), 778–779.
53. 53 Ramaekers, V.T., et al. Folinic acid treatment for schizophrenia associated with folate receptor autoantibodies. Mol Genet Metab 113 (2014), 307–314.
54. 54• Tsang, B.L., et al. Assessing the association between the methylenetetrahydrofolate reductase (MTHFR) 677C>T polymorphism and blood folate concentrations: a systematic review and meta-analysis of trials and observational studies. Am J Clin Nutr 101 (2015), 1286–1294 Excellent study demonstrating the effect of gene polymorphisms on folate status.
55. 55 Gilbody, S., Lewis, S., Lightfoot, T., Methylenetetrahydrofolate reductase (MTHFR) genetic polymorphisms and psychiatric disorders: a HuGE review. Am J Epidemiol 165 (2007), 1–13.
56. 56 Roffman, J.L., MTHFR 677C>T effects on anterior cingulate structure and function during response monitoring in schizophrenia: a preliminary study. Brain Imaging Behav 5 (2011), 65–75.
57. 57 Roffman, J.L., et al. A hypomethylating variant of MTHFR, 677C>T, blunts the neural response to errors in patients with schizophrenia and healthy individuals. PLoS One, 6, 2011, e25253.
58. 58 Bailey, L.B., Gregory, J.F. 3rd, Folate metabolism and requirements. J Nutr 129 (1999), 779–782.
59. 59 Anonymous, Folate and vitamin B12 deficiencies. Proceedings of a WHO technical consultation held 18–21 October, 2005, in Geneva, Switzerland. Food Nutr Bull 29:Suppl. 2 (2008), S1–246.
60. 60 Freeman, M.P., Complementary and alternative medicine (CAM): considerations for the treatment of major depressive disorder. J Clin Psychiatry 70:Suppl. 5 (2009), 4–6.
61. 61 Pineda, M., Cerebral folate deficiency and leukoencephalopathy caused by a mitochondrial DNA deletion. Ann Neurol 59 (2006), 394–398.
62. 62 Wollack, J.B., Characterization of folate uptake by choroid plexus epithelial cells in a rat primary culture model. J Neurochem 104 (2008), 1494–1503.
63. 63 Hunnicutt, L.E., Prevalence and natural host range of Homalodisca coagulata virus-1 (HoCV-1). Arch Virol 153 (2008), 61–67.
64. 64 House, A.A., Effect of B-vitamin therapy on progression of diabetic nephropathy: a randomized controlled trial. JAMA 303 (2010), 1603–1609.
65. 65 Burgos-Silva, M., et al. Adipose tissue-derived stem cells reduce acute and chronic kidney damage in mice. PLoS One, 10, 2015, e0142183.
66. 66 Li, X., Dai, J., Qiu, Y., Zhang, X., 4-1BB-mediated signals confer protection against folic acid-induced nephrotoxicity. Kidney Blood Press Res 36 (2012), 10–17.
67. 67 Soofi, A., Zhang, P., Dressler, G.R., Kielin/chordin-like protein attenuates both acute and chronic renal injury. J Am Soc Nephrol 24 (2013), 897–905.
68. 68 Ward, B.W., Schiller, J.S., Goodman, R.A., Multiple chronic conditions among US adults: a 2012 update. Prev Chronic Dis, 11, 2014, E62.
69. 69 Kanner, A.A., Serum S100beta: a noninvasive marker of blood–brain barrier function and brain lesions. Cancer 97 (2003), 2806–2813.
70. 70• Sweeney, M.D., Sagare, A.P., Zlokovic, B.V., Cerebrospinal fluid biomarkers of neurovascular dysfunction in mild dementia and Alzheimer's disease. J Cereb Blood Flow Metab 35 (2015), 1055–1068.
71. 71 Jaeger, L.B., Lipopolysaccharide alters the blood–brain barrier transport of amyloid beta protein: a mechanism for inflammation in the progression of Alzheimer's disease. Brain Behav Immun 23 (2009), 507–5177.
72. 72 Alyautdin, R., Khalin, I., Nafeeza, M.I., Haron, M.H., Kuznetsov, D., Nanoscale drug delivery systems and the blood–brain barrier. Int J Nanomed 9 (2014), 795–811.
73. 73 Steinfeld, R., Folate receptor alpha defect causes cerebral folate transport deficiency: a treatable neurodegenerative disorder associated with disturbed myelin metabolism. Am J Hum Genet 85 (2009), 354–363.
74. 74 Torres, A., CSF 5-methyltetrahydrofolate serial monitoring to guide treatment of congenital folate malabsorption due to proton-coupled folate transporter (PCFT) deficiency. JIMD Rep 24 (2015), 91–96.
75. 75 Perez-Duenas, B., Progressive ataxia and myoclonic epilepsy in a patient with a homozygous mutation in the FOLR1 gene. J Inherit Metab Dis 33 (2010), 795–802.
76. 76 Al-Baradie, R.S., Chaudhary, M.W., Diagnosis and management of cerebral folate deficiency. A form of folinic acid-responsive seizures. Neurosciences (Riyadh) 19 (2014), 312–316.
77. 77 Ramaekers, V.T., Weis, J., Sequeira, J.M., Quadros, E.V., Blau, N., Mitochondrial complex I encephalomyopathy and cerebral 5-methyltetrahydrofolate deficiency. Neuropediatrics 38 (2007), 184–187.
78. 78 Wang, Q., et al. The first Chinese case report of hereditary folate malabsorption with a novel mutation on SLC46A1. Brain Dev 37 (2015), 163–167.